FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Giulio Marchesini

Research Profile

Disorders

Anatomy

Livers

Chemicals & Drugs

Activities & Behaviors

Questionnaires

Concepts & Ideas

Procedures

Cognitive Therapy

Co-author Network

Publications

TOP 3
Riccardo Dalle Grave; Enzo Grossi; Edoardo Mannucci; Giulio Marchesini; Nazario Melchionda; Enrico Molinari; Franco Tomasi; Paolo Beck-Peccoz; Ottavio Bosello; Simona Calugi; Angelo Compare; Massimo Cuzzolaro
Personality features of obese women in relation to binge eating and night eating.
Gabriele Forlani; Chiara Caselli; Elena Centis; Arianna Mazzotti; Simona Moscatiello; Chiara Nuccitelli; Giulio Marchesini
A psychological support program for individuals with Type 1 diabetes.
Angelo Compare; Giulio Marchesini; Enrico Molinari; Simona Calugi; Riccardo Dalle Grave
Emotion-focused therapy and dietary counseling for obese patients with binge eating disorder: a propensity score-adjusted study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Giulio Marchesini (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Riccardo Dalle Grave; Enzo Grossi; Edoardo Mannucci; Giulio Marchesini; Nazario Melchionda; Enrico Molinari; Franco Tomasi; Paolo Beck-Peccoz; Ottavio Bosello; Simona Calugi; Angelo Compare; Massimo Cuzzolaro
Personality features of obese women in relation to binge eating and night eating.
Psychiatry research 2013;207(1-2):86-91.
2013: Gabriele Forlani; Chiara Caselli; Elena Centis; Arianna Mazzotti; Simona Moscatiello; Chiara Nuccitelli; Giulio Marchesini
A psychological support program for individuals with Type 1 diabetes.
Acta diabetologica 2013;50(2):209-16.
2013: Angelo Compare; Giulio Marchesini; Enrico Molinari; Simona Calugi; Riccardo Dalle Grave
Emotion-focused therapy and dietary counseling for obese patients with binge eating disorder: a propensity score-adjusted study.
Psychotherapy and psychosomatics 2013;82(3):193-4.
2012: Simona Calugi; Angelo Compare; E Dall'Aglio; Riccardo Dalle Grave; Giulio Marchesini; M L Petroni
Weight loss and clinical characteristics of young adults patients seeking treatment at medical centers: data from the QUOVADIS Study.
Eating and weight disorders : EWD 2012;17(4):e314-9.
2012: E Centis; R Di Luzio; Giulio Marchesini; Rebecca Marzocchi; Simona Moscatiello; S Salardi; Nicola Villanova
A controlled, class-based multicomponent intervention to promote healthy lifestyle and to reduce the burden of childhood obesity.
Pediatric obesity 2012;7(6):436-45.
2012: Domenico Motola; Carlo Piccinni; Chiara Biagi; Giulio Marchesini; Anna Marra; Emanuel Raschi; Elisabetta Poluzzi
Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database.
Drug safety : an international journal of medical toxicology and drug experience 2012;35(4):315-23.
2012: Riccardo Dalle Grave; Simona Calugi; Giulio Marchesini
Objective and subjective binge eating in underweight eating disorders: associated features and treatment outcome.
The International journal of eating disorders 2012;45(3):370-6.
2012: Francesco Di Pierro; Rebecca Marzocchi; Valentina Soverini; Nicola Villanova; Federica Agostini; Giulio Marchesini
Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control.
Diabetes, metabolic syndrome and obesity : targets and therapy 2012;5():213-7.
2012: Andrea Fabbri; Marcello Galvani; Giulio Marchesini; Filippo Ottani; Alberto Vandelli
Predicting unfavorable outcome in subjects with diagnosis of chest pain of undifferentiated origin.
The American journal of emergency medicine 2012;30(1):61-7.
2011: Simona Moscatiello; Anna Simona Sasdelli; Raffaella Di Luzio; Giulio Marchesini
Managing the combination of nonalcoholic fatty liver disease and metabolic syndrome.
Expert opinion on pharmacotherapy 2011;12(17):2657-72.
2011: Valentina Soverini; Alberto Bruno; Elisabetta Bugianesi; Gabriele Forlani; Vincenzo La Mura; Mario Massarone; Arianna Mazzotti; Marcello Persico; Federico Salamone; Giulio Marchesini
HBV and HCV infection in type 2 diabetes mellitus: a survey in three diabetes units in different Italian areas.
Acta diabetologica 2011;48(4):337-43.
2011: Raffaella Rossini; Valentina Soverini; Giulietta Tarrini; Riccardo Dalle Grave; Silvia Di Domizio; Arianna Mazzotti; Simona Moscatiello; Andreina Romano; Giulio Marchesini
Effects of cognitive-behavioral treatment for weight loss in family members.
Journal of the American Dietetic Association 2011;111(11):1712-9.
2011: Andrea Fabbri; Franco Servadei; Giulio Marchesini; Angelica Raggi; Alberto Vandelli
Analysis of different decision aids for clinical use in pediatric head injury in an emergency department of a general hospital.
The Journal of trauma 2011;70(5):E79-83.
2011: Giulio Marchesini; Gabriele Forlani; E Rossi; A Berti; M De Rosa
The direct economic cost of pharmacologically-treated diabetes in Italy-2006. The ARNO observatory.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2011;21(5):339-46.
2011: Simona Moscatiello; Raffaella Di Luzio; Elisabetta Bugianesi; Alessandro Suppini; Ingrid J Hickman; Silvia Di Domizio; Riccardo Dalle Grave; Giulio Marchesini
Cognitive-behavioral treatment of nonalcoholic Fatty liver disease: a propensity score-adjusted observational study.
Obesity (Silver Spring, Md.) 2011;19(4):763-70.
2011: Riccardo Dalle Grave; Simona Calugi; Antonella Ruocco; Giulio Marchesini
Night eating syndrome and weight loss outcome in obese patients.
The International journal of eating disorders 2011;44(2):150-6.
2011: Luca VC Valenti; S Moscatiello; E Vanni; Anna Ludovica Fracanzani; E Bugianesi; Silvia Fargion; Giulio Marchesini
Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational study.
QJM : monthly journal of the Association of Physicians 2011;104(2):141-9.
2011: Giampaolo Bianchi; Elisabetta Bugianesi; Jan Frystyk; Lise Tarnow; Allan Flyvbjerg; Giulio Marchesini
Adiponectin isoforms, insulin resistance and liver histology in nonalcoholic fatty liver disease.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2011;43(1):73-7.
2010: Elisabetta Bugianesi; Simona Moscatiello; M F Ciaravella; Giulio Marchesini
Insulin resistance in nonalcoholic fatty liver disease.
Current pharmaceutical design 2010;16(17):1941-51.
2010: R Di Luzio; Simona Moscatiello; Giulio Marchesini
Role of nutrition in gastrointestinal oncological patients.
European review for medical and pharmacological sciences 2010;14(4):277-84.
2010: Paola Loria; L E Adinolfi; Stefano Bellentani; E Bugianesi; A Grieco; S Fargion; A Gasbarrini; C Loguercio; Amedeo Lonardo; Giulio Marchesini; F Marra; M Persico; D Prati; G Svegliati- Baroni
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2010;42(4):272-82.
2010: Riccardo Dalle Grave; Simona Calugi; Maria Letizia Petroni; Silvia Di Domizio; Giulio Marchesini
Weight management, psychological distress and binge eating in obesity. A reappraisal of the problem.
Appetite 2010;54(2):269-73.
2010: Valentina Soverini; Simona Moscatiello; Nicola Villanova; Elisabetta Ragni; Silvia Di Domizio; Giulio Marchesini
Metabolic syndrome and insulin resistance in subjects with morbid obesity.
Obesity surgery 2010;20(3):295-301.
2010: Elena Centis; Rebecca Marzocchi; Silvia Di Domizio; Maria Francesca Ciaravella; Giulio Marchesini
The effect of lifestyle changes in non-alcoholic fatty liver disease.
Digestive diseases (Basel, Switzerland) 2010;28(1):267-73.
2009: Ester Vanni; Maria Lorena Abate; Elena Gentilcore; Ingrid Hickman; Roberto Gambino; Maurizio Cassader; Antonina Smedile; Ele Ferrannini; Mario Rizzetto; Giulio Marchesini; Amalia Gastaldelli; Elisabetta Bugianesi
Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C.
Hepatology (Baltimore, Md.) 2009;50(3):697-706.
2009: Simona Calugi; Riccardo Dalle Grave; Giulio Marchesini
Night eating syndrome in class II-III obesity: metabolic and psychopathological features.
International journal of obesity (2005) 2009;33(8):899-904.
2009: Riccardo Dalle Grave; Simona Calugi; Giulio Marchesini
Self-induced vomiting in eating disorders: Associated features and treatment outcome.
Behaviour research and therapy 2009;47(8):680-4.
2009: Gabriele Forlani; C Lorusso; Simona Moscatiello; V Ridolfi; Nazario Melchionda; S Di Domizio; Giulio Marchesini
Are behavioural approaches feasible and effective in the treatment of type 2 diabetes? A propensity score analysis vs. prescriptive diet.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2009;19(5):313-20.
2008: Riccardo Dalle Grave; Simona Calugi; Giulio Marchesini
Is amenorrhea a clinically useful criterion for the diagnosis of anorexia nervosa?
Behaviour research and therapy 2008;46(12):1290-4.
2008: Riccardo Dalle Grave; Simona Calugi; Giulio Marchesini
Underweight eating disorder without over-evaluation of shape and weight: Atypical anorexia nervosa?
The International journal of eating disorders 2008;41(8):705-12.
2008: Giampaolo Bianchi; Caterina Lorusso; Rebecca Marzocchi; Valentina Ridolfi; Giulio Marchesini
Nutritional treatment of chronic liver failure.
Hepatology research : the official journal of the Japan Society of Hepatology 2008;38 Suppl 1():S93-S101.
2008: Giulio Marchesini; Simona Moscatiello; Silvia Di Domizio; Gabriele Forlani
Obesity-associated liver disease.
The Journal of clinical endocrinology and metabolism 2008;93(11 Suppl 1):S74-80.
2008: Giampaolo Bianchi; Giulio Marchesini; Rebecca Marzocchi; Antonio Daniele Pinna; Marco Zoli
Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008;14(11):1648-54.
2008: Simona Moscatiello; Rebecca Marzocchi; Nicola Villanova; Elisabetta Bugianesi; Giulio Marchesini
Which treatment for nonalcoholic fatty liver disease?
Mini reviews in medicinal chemistry 2008;8(8):767-75.
2008: Riccardo Dalle Grave; Simona Calugi; Giulio Marchesini
Compulsive exercise to control shape or weight in eating disorders: prevalence, associated features, and treatment outcome.
Comprehensive psychiatry 2008;49(4):346-52.
2008: Giulio Marchesini; Valentina Ridolfi; Valentina Nepoti
Hepatotoxicity of fast food?
Gut 2008;57(5):568-70.
2008: Riccardo Dalle Grave; Simona Calugi; Francesca Brambilla; Giulio Marchesini
Personality dimensions and treatment drop-outs among eating disorder patients treated with cognitive behavior therapy.
Psychiatry research 2008;158(3):381-8.
2008: Gabriele Forlani; Procolo Di Bonito; Edoardo Mannucci; B Capaldo; S Genovese; M Orrasch; L Scaldaferri; P Di Bartolo; P Melandri; A Dei Cas; I Zavaroni; Giulio Marchesini
Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome.
Journal of endocrinological investigation 2008;31(2):146-52.
2008: Stefano Bellentani; Riccardo Dalle Grave; Alessandro Suppini; Giulio Marchesini
Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach.
Hepatology (Baltimore, Md.) 2008;47(2):746-54.
2008: Francesco Corica; Andrea Corsonello; Giovanni Apolone; Edoardo Mannucci; M Lucchetti; C Bonfiglio; Nazario Melchionda; Giulio Marchesini
Metabolic syndrome, psychological status and quality of life in obesity: the QUOVADIS Study.
International journal of obesity (2005) 2008;32(1):185-91.
2007: Valerio Nobili; Matilde Marcellini; Giulio Marchesini; Ester Vanni; Melania Manco; Alberto Villani; Elisabetta Bugianesi
Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in children.
Diabetes care 2007;30(10):2638-40.
2007: Riccardo Dalle Grave; Massimo Cuzzolaro; Simona Calugi; Franco Tomasi; Flavia Temperilli; Giulio Marchesini
The effect of obesity management on body image in patients seeking treatment at medical centers.
Obesity (Silver Spring, Md.) 2007;15(9):2320-7.
2007: Rita Manini; Gabriele Forlani; Simona Moscatiello; Claudio Zannoni; Rebecca Marzocchi; Giulio Marchesini
Insulin glargine improves glycemic control and health-related quality of life in type 1 diabetes.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2007;17(7):493-8.
2007: Giuseppe Marano; Massimo Cuzzolaro; G Vetrone; P E Garfinkel; F Temperilli; G Spera; Riccardo Dalle Grave; Simona Calugi; Giulio Marchesini
Validating the Body Uneasiness Test (BUT) in obese patients.
Eating and weight disorders : EWD 2007;12(2):70-82.
2007: Elisabetta Bugianesi; Ester Vanni; Giulio Marchesini
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes.
Current diabetes reports 2007;7(3):175-80.
2007: Luca VC Valenti; Anna Ludovica Fracanzani; Paola Dongiovanni; Elisabetta Bugianesi; Giulio Marchesini; Paola Manzini; Ester Vanni; Silvia Fargion
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control study.
The American journal of gastroenterology 2007;102(6):1251-8.
2007: Riccardo Dalle Grave; Simona Calugi; Francesca Brambilla; Giovanni Abbate-Daga; Secondo Fassino; Giulio Marchesini
The effect of inpatient cognitive-behavioral therapy for eating disorders on temperament and character.
Behaviour research and therapy 2007;45(6):1335-44.
2007: Maria Letizia Petroni; Nicola Villanova; Sebastiano Avagnina; Maria Antonia Fusco; Giuseppe Fatati; Angelo Compare; Giulio Marchesini
Psychological distress in morbid obesity in relation to weight history.
Obesity surgery 2007;17(3):391-9.
2007: Elisabetta Poluzzi; Petar Strahinja; Alberto Vaccheri; Antonio Vargiu; Maria Chiara Silvani; Domenico Motola; Giulio Marchesini; Fabrizio De Ponti; Nicola Montanaro
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverage.
British journal of clinical pharmacology 2007;63(3):346-55.
2007: Giulio Marchesini; Rebecca Marzocchi
Metabolic syndrome and NASH.
Clinics in liver disease 2007;11(1):105-17, ix.
2007: Simona Moscatiello; Rita Manini; Giulio Marchesini
Diabetes and liver disease: an ominous association.
Nutrition, metabolism, and cardiovascular diseases : NMCD 2007;17(1):63-70.
2006: Elisabetta Bugianesi; Giulio Marchesini; Elena Gentilcore; Ian Homer Y Cua; Ester Vanni; Mario Rizzetto; Jacob George
Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
Hepatology (Baltimore, Md.) 2006;44(6):1648-55.
2006: Francesco Corica; Andrea Corsonello; Giovanni Apolone; Maria Lucchetti; Nazario Melchionda; Giulio Marchesini
Construct validity of the Short Form-36 Health Survey and its relationship with BMI in obese outpatients.
Obesity (Silver Spring, Md.) 2006;14(8):1429-37.
2006: enzo grossi; Riccardo Dalle Grave; Edoardo Mannucci; Enrico Molinari; Angelo Compare; Massimo Cuzzolaro; Giulio Marchesini
Complexity of attrition in the treatment of obesity: clues from a structured telephone interview.
International journal of obesity (2005) 2006;30(7):1132-7.
2006: Gabriele Forlani; Claudio Zannoni; G Tarrini; Nazario Melchionda; Giulio Marchesini
An empowerment-based educational program improves psychological well-being and health-related quality of life in Type 1 diabetes.
Journal of endocrinological investigation 2006;29(5):405-12.
2006: Nicola Villanova; Francesca Pasqui; S Burzacchini; Gabriele Forlani; Rita Manini; A Suppini; Nazario Melchionda; Giulio Marchesini
A physical activity program to reinforce weight maintenance following a behavior program in overweight/obese subjects.
International journal of obesity (2005) 2006;30(4):697-703.
2006: Nazario Melchionda; Gabriele Forlani; Lucia La Rovere; Paola Argnani; Fausto Trevisani; Donato Zocchi; Giandomenico Savorani; Anna Covezzoli; Marisa De Rosa; Giulio Marchesini
Disease management of the metabolic syndrome in a community: study design and process analysis on baseline data.
Metabolic syndrome and related disorders 2006;4(1):7-16.
2005: Fernanda Cerrelli; Rita Manini; Gabriele Forlani; Luisa Baraldi; Nazario Melchionda; Giulio Marchesini
Eating behavior affects quality of life in type 2 diabetes mellitus.
Eating and weight disorders : EWD 2005;10(4):251-7.
2005: Giulio Marchesini; Alessandro Suppini; Gabriele Forlani
NAFLD treatment: cognitive-behavioral therapy has entered the arena.
Journal of hepatology 2005;43(6):926-8.
2005: Riccardo Dalle Grave; Simona Calugi; Enrico Molinari; Maria Letizia Petroni; Mario Bondi; Angelo Compare; Giulio Marchesini
Weight loss expectations in obese patients and treatment attrition: an observational multicenter study.
Obesity research 2005;13(11):1961-9.
2005: Elisabetta Bugianesi; Arthur J McCullough; Giulio Marchesini
Insulin resistance: a metabolic pathway to chronic liver disease.
Hepatology (Baltimore, Md.) 2005;42(5):987-1000.
2005: Giulio Marchesini; Stefania Natale; Rita Manini; Federica Agostini
Review article: the treatment of fatty liver disease associated with the metabolic syndrome.
Alimentary pharmacology & therapeutics 2005;22 Suppl 2():37-9.
2005: Riccardo Dalle Grave; Nazario Melchionda; Simona Calugi; E Centis; A Tufano; Giuseppe Fatati; M A Fusco; Giulio Marchesini
Continuous care in the treatment of obesity: an observational multicentre study.
Journal of internal medicine 2005;258(3):265-73.
2005: Giulio Marchesini; Rebecca Marzocchi; Federica Agostini; Elisabetta Bugianesi
Nonalcoholic fatty liver disease and the metabolic syndrome.
Current opinion in lipidology 2005;16(4):421-7.
2005: Nicola Villanova; Simona Moscatiello; Stefano Ramilli; Elisabetta Bugianesi; Donatella Magalotti; Ester Vanni; Marco Zoli; Giulio Marchesini
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease.
Hepatology (Baltimore, Md.) 2005;42(2):473-80.
2005: Giampaolo Bianchi; Giulio Marchesini; Francesco Nicolino; R Graziani; D Sgarbi; Carmela Loguercio; Roberto Abbiati; Marco Zoli
Psychological status and depression in patients with liver cirrhosis.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2005;37(8):593-600.
2005: Giulio Marchesini; Rebecca Marzocchi; Marianna Noia; Giampaolo Bianchi
Branched-chain amino acid supplementation in patients with liver diseases.
The Journal of nutrition 2005;135(6 Suppl):1596S-601S.
2005: Elisabetta Bugianesi; Uberto Pagotto; Rita Manini; Ester Vanni; Amalia Gastaldelli; Rosaria de Iasio; Elena Gentilcore; Stefania Natale; Maurizio Cassader; Mario Rizzetto; Renato Pasquali; Giulio Marchesini
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity.
The Journal of clinical endocrinology and metabolism 2005;90(6):3498-504.
2005: Elisabetta Bugianesi; Elena Gentilcore; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Ezio David; Mario Rizzetto; Giulio Marchesini
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver disease.
The American journal of gastroenterology 2005;100(5):1082-90.
2005: Giulio Marchesini; S Avagnina; E G Barantani; A M Ciccarone; F Corica; E Dall'Aglio; Riccardo Dalle Grave; P S Morpurgo; Franco Tomasi; Ester Vitacolonna
Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome.
Journal of endocrinological investigation 2005;28(4):333-9.
2005: Giampaolo Bianchi; Rebecca Marzocchi; Federica Agostini; Giulio Marchesini
Update on branched-chain amino acid supplementation in liver diseases.
Current opinion in gastroenterology 2005;21(2):197-200.
2005: Giulio Marchesini; Gabriele Forlani; Elisabetta Bugianesi
Is liver disease a threat to patients with metabolic disorders?
Annals of medicine 2005;37(5):333-46.
2005: Giampaolo Bianchi; Rebecca Marzocchi; Federica Agostini; Giulio Marchesini
Update on nutritional supplementation with branched-chain amino acids.
Current opinion in clinical nutrition and metabolic care 2005;8(1):83-7.
2004: Riccardo Dalle Grave; Simona Calugi; Flavia Magri; Massimo Cuzzolaro; Elisabetta Dall'aglio; Lucio Lucchin; Nazario Melchionda; Giulio Marchesini
Weight loss expectations in obese patients seeking treatment at medical centers.
Obesity research 2004;12(12):2005-12.
2004: Elisabetta Bugianesi; Rebecca Marzocchi; Nicola Villanova; Giulio Marchesini
Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment.
Best practice & research. Clinical gastroenterology 2004;18(6):1105-16.
2004: Giulio Marchesini; Massimo Cuzzolaro; Edoardo Mannucci; Riccardo Dalle Grave; M Gennaro; Franco Tomasi; E G Barantani; Nazario Melchionda
Weight cycling in treatment-seeking obese persons: data from the QUOVADIS study.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2004;28(11):1456-62.
2004: Donatella Magalotti; Giulio Marchesini; Stefano Ramilli; Annalisa Berzigotti; Giampaolo Bianchi; Marco Zoli
Splanchnic haemodynamics in non-alcoholic fatty liver disease: effect of a dietary/pharmacological treatment. A pilot study.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2004;36(6):406-11.
2004: Giulio Marchesini; Giampaolo Bianchi; paola lucidi; Nicola Villanova; Marco Zoli; Pierpaolo De Feo
Plasma ghrelin concentrations, food intake, and anorexia in liver failure.
The Journal of clinical endocrinology and metabolism 2004;89(5):2136-41.
2004: Giulio Marchesini; Gabriele Forlani; Fernanda Cerrelli; Rita Manini; Stefania Natale; Luisa Baraldi; G Ermini; Giancarlo Savorani; D Zocchi; Nazario Melchionda
WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes.
Diabetic medicine : a journal of the British Diabetic Association 2004;21(4):383-7.
2004: Giulio Marchesini; Nazario Melchionda; Giovanni Apolone; Massimo Cuzzolaro; Edoardo Mannucci; Francesco Corica; enzo grossi
The metabolic syndrome in treatment-seeking obese persons.
Metabolism: clinical and experimental 2004;53(4):435-40.
2004: Elisabetta Bugianesi; Claudio Zannoni; Ester Vanni; Rebecca Marzocchi; Giulio Marchesini
Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship?
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2004;36(3):165-73.
2004: Giulio Marchesini; A Pontiroli; G Salvioli; R F Novi; Ester Vitacolonna; C Taboga; A M Ciccarone; enzo grossi
Snoring, hypertension and Type 2 diabetes in obesity. Protection by physical activity.
Journal of endocrinological investigation 2004;27(2):150-7.
2004: Giampaolo Bianchi; V Zaccheroni; E Solaroli; Fabio Vescini; R Cerutti; M Zoli; Giulio Marchesini
Health-related quality of life in patients with thyroid disorders.
Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2004;13(1):45-54.
2004: Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Rebecca Marzocchi; Claudio Zannoni; Ester Vanni; Rita Manini; Mario Rizzetto; Nazario Melchionda
Non-alcoholic steatohepatitis in patients cared in metabolic units.
Diabetes research and clinical practice 2004;63(2):143-51.
2004: Elisabetta Bugianesi; Paola Manzini; SERGIO D'ANTICO; Ester Vanni; Filomena Longo; Nicola Leone; Paola Massarenti; Antonio Piga; Giulio Marchesini; Mario Rizzetto
Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver.
Hepatology (Baltimore, Md.) 2004;39(1):179-87.
2003: Giulio Marchesini; Uberto Pagotto; Elisabetta Bugianesi; Rosaria de Iasio; Rita Manini; Ester Vanni; Renato Pasquali; Nazario Melchionda; Mario Rizzetto
Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance.
The Journal of clinical endocrinology and metabolism 2003;88(12):5674-9.
2003: Giulio Marchesini; Stefania Natale; F Tiraferri; Andreas Tartaglia; Simona Moscatiello; L Marchesini Reggiani; Nicola Villanova; Gabriele Forlani; Nazario Melchionda
The burden of obesity on everyday life: a role for osteoarticular and respiratory diseases.
Diabetes, nutrition & metabolism 2003;16(5-6):284-90.
2003: Giampaolo Bianchi; Giulio Marchesini; Nicoletta Brunetti; E Manicardi; F Montuschi; Raffaela Chianese; Marco Zoli
Impaired insulin-mediated amino acid plasma disappearance in non-alcoholic fatty liver disease: a feature of insulin resistance.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2003;35(10):722-7.
2003: Nazario Melchionda; L Besteghi; S Di Domizio; Francesca Pasqui; C Nuccitelli; S Migliorini; Luisa Baraldi; Stefania Natale; Rita Manini; M Bellini; C Belsito; Gabriele Forlani; Giulio Marchesini
Cognitive behavioural therapy for obesity: one-year follow-up in a clinical setting.
Eating and weight disorders : EWD 2003;8(3):188-93.
2003: Giulio Marchesini; M Bellini; Stefania Natale; C Belsito; S Isacco; C Nuccitelli; Francesca Pasqui; Luisa Baraldi; Gabriele Forlani; Nazario Melchionda
Psychiatric distress and health-related quality of life in obesity.
Diabetes, nutrition & metabolism 2003;16(3):145-54.
2003: Giulio Marchesini; Giampaolo Bianchi; Manuela Merli; Piero Amodio; Carmine Panella; Carmela Loguercio; Fillipo Rossi Fanelli; Roberto Abbiati
Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trial.
Gastroenterology 2003;124(7):1792-801.
2003: Nazario Melchionda; Giulio Marchesini; giovanni Apolone; Massimo Cuzzolaro; Edoardo Mannucci; enzo grossi
The QUOVADIS Study: features of obese Italian patients seeking treatment at specialist centers.
Diabetes, nutrition & metabolism 2003;16(2):115-24.
2003: Giulio Marchesini; Elisabetta Bugianesi; Gabriele Forlani; Fernanda Cerrelli; Marco Lenzi; Rita Manini; Stefania Natale; Ester Vanni; Nicola Villanova; Nazario Melchionda; Mario Rizzetto
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
Hepatology (Baltimore, Md.) 2003;37(4):917-23.
2003: Giampaolo Bianchi; Carmela Loguercio; D Sgarbi; Roberto Abbiati; Nicoletta Brunetti; Teresa De Simone; Marco Zoli; Giulio Marchesini
Reduced quality of life of patients with hepatocellular carcinoma.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2003;35(1):46-54.
2002: Giulio Marchesini; Stefania Natale; S Chierici; Rita Manini; L Besteghi; S Di Domizio; A Sartini; Francesca Pasqui; Luisa Baraldi; Gabriele Forlani; Nazario Melchionda
Effects of cognitive-behavioural therapy on health-related quality of life in obese subjects with and without binge eating disorder.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2002;26(9):1261-7.
2002: Elisabetta Bugianesi; Nicola Leone; Ester Vanni; Giulio Marchesini; Franco Brunello; Patrizia Carucci; Alessandro Musso; Paolo De Paolis; Lorenzo Capussotti; Mauro Salizzoni; Mario Rizzetto
Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.
Gastroenterology 2002;123(1):134-40.
2002: Giampaolo Bianchi; Mara Brizi; Rita Manini; Andrea Fabbri; Stefano Loffreda; Marco Zoli; Giulio Marchesini
Effects of long-term oral misoprostol administration on hepatic amino acid-nitrogen metabolism in patients with cirrhosis.
Journal of hepatology 2002;37(1):15-21.
2002: Giulio Marchesini; Rita Manini; Giampaolo Bianchi; Simonetta Sassi; Stefania Natale; Simona Chierici; Francesca Visani; Luisa Baraldi; Gabriele Forlani; Nazario Melchionda
Homocysteine and psychological traits: a study in obesity.
Nutrition (Burbank, Los Angeles County, Calif.) 2002;18(5):403-7.
2002: Nazario Melchionda; Gabriele Forlani; Giulio Marchesini; Luisa Baraldi; Stefania Natale
WHO and ADA criteria for the diagnosis of diabetes mellitus in relation to body mass index. Insulin sensitivity and secretion in resulting subcategories of glucose tolerance.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2002;26(1):90-6.
2001: Micaela Susca; Alberto Grassi; Daniela Zauli; Umberto Volta; Marco Lenzi; Giulio Marchesini; Francesco B Bianchi; Giorgio Ballardini
Liver inflammatory cells, apoptosis, regeneration and stellate cell activation in non-alcoholic steatohepatitis.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2001;33(9):768-77.
2001: Giulio Marchesini; Mara Brizi; Giampaolo Bianchi; S Tomassetti; Marco Zoli; Nazario Melchionda
Metformin in non-alcoholic steatohepatitis.
Lancet 2001;358(9285):893-4.
2001: Giulio Marchesini; Mara Brizi; Giampaolo Bianchi; S Tomassetti; Elisabetta Bugianesi; Marco Lenzi; A J McCullough; Stefania Natale; Gabriele Forlani; Nazario Melchionda
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
Diabetes 2001;50(8):1844-50.
2001: Giulio Marchesini; V Zaccheroni; Mara Brizi; Stefania Natale; Gabriele Forlani; Giampaolo Bianchi; Luisa Baraldi; Nazario Melchionda
Systemic prostaglandin E1 infusion and hepatic aminonitrogen to urea nitrogen conversion in patients with type 2 diabetes in poor metabolic control.
Metabolism: clinical and experimental 2001;50(2):253-8.
2001: Giulio Marchesini; Giampaolo Bianchi; P Amodio; Francesco Salerno; Manuela Merli; Carmine Panella; Carmela Loguercio; giovanni Apolone; M Niero; Roberto Abbiati
Factors associated with poor health-related quality of life of patients with cirrhosis.
Gastroenterology 2001;120(1):170-8.
2000: Giampaolo Bianchi; Mara Brizi; B Rossi; M Ronchi; G Grossi; Giulio Marchesini
Synthesis of glutathione in response to methionine load in control subjects and in patients with cirrhosis.
Metabolism: clinical and experimental 2000;49(11):1434-9.
2000: Giampaolo Bianchi; Carmela Loguercio; D Sgarbi; Roberto Abbiati; C H Chen; M Di Pierro; D Disalvo; Stefania Natale; Giulio Marchesini
Reduced quality of life in patients with chronic hepatitis C: effects of interferon treatment.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2000;32(5):398-405.
2000: Giulio Marchesini; E Solaroli; Luisa Baraldi; Stefania Natale; S Migliorini; F Visani; Gabriele Forlani; Nazario Melchionda
Health-related quality of life in obesity: the role of eating behaviour.
Diabetes, nutrition & metabolism 2000;13(3):156-64.
2000: Giulio Marchesini; Giampaolo Bianchi; B Rossi; M Muggeo; E Bonora
Effects of hyperglycaemia and hyperinsulinaemia on plasma amino acid levels in obese subjects with normal glucose tolerance.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24(5):552-8.
2000: Giulio Marchesini; Giampaolo Bianchi; B Rossi; Mara Brizi; Nazario Melchionda
Nutritional treatment with branched-chain amino acids in advanced liver cirrhosis.
Journal of gastroenterology 2000;35 Suppl 12():7-12.
1999: Giampaolo Bianchi; E Solaroli; V Zaccheroni; Gabriele Grossi; Alberto M Bargossi; Nazario Melchionda; Giulio Marchesini
Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1999;31(11):620-4.
1999: Giulio Marchesini; Mara Brizi; A M Morselli-Labate; Giampaolo Bianchi; Elisabetta Bugianesi; A J McCullough; Gabriele Forlani; Nazario Melchionda
Association of nonalcoholic fatty liver disease with insulin resistance.
The American journal of medicine 1999;107(5):450-5.
1999: Giampaolo Bianchi; Gabriele Grossi; Alberto M Bargossi; P L Fiorella; Giulio Marchesini
Can oxypurines plasma levels classify the type of physical exercise?
The Journal of sports medicine and physical fitness 1999;39(2):123-7.
1999: Giulio Marchesini; M Ronchi; Gabriele Forlani; Elisabetta Bugianesi; Giampaolo Bianchi; Anna Fabbri; Marco Zoli; Nazario Melchionda
Cardiovascular disease in cirrhosis--a point-prevalence study in relation to glucose tolerance.
The American journal of gastroenterology 1999;94(3):655-62.
1999: Andrea Fabbri; Donatella Magalotti; Mara Brizi; Giampaolo Bianchi; Marco Zoli; Giulio Marchesini
Prostaglandin E1 infusion and functional hepatic flow in control subjects and in patients with cirrhosis.
Digestive diseases and sciences 1999;44(2):377-84.
1999: Marco Zoli; Donatella Magalotti; Giampaolo Bianchi; C Gueli; C Orlandini; M Grimaldi; Giulio Marchesini
Total and functional hepatic blood flow decrease in parallel with ageing.
Age and ageing 1999;28(1):29-33.
1998: Giulio Marchesini; Elisabetta Bugianesi; M Ronchi; R Flamia; Karl Thomaseth; Giovanni Pacini
Zinc supplementation improves glucose disposal in patients with cirrhosis.
Metabolism: clinical and experimental 1998;47(7):792-8.
1998: Andrea Fabbri; Donatella Magalotti; Giulio Marchesini; Mara Brizi; Giampaolo Bianchi; Marco Zoli
Effects of systemic prostaglandin E1 on splanchnic and peripheral haemodynamics in control subjects and in patients with cirrhosis.
Prostaglandins & other lipid mediators 1998;55(4):209-18.
1998: Andrea Fabbri; Giampaolo Bianchi; Mara Brizi; Elisabetta Bugianesi; Donatella Magalotti; Marco Zoli; Giulio Marchesini
Effects of systemic prostaglandin E1 on hepatic amino acid-nitrogen metabolism in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1998;27(3):815-21.
1997: Giampaolo Bianchi; Giulio Marchesini; Anna Fabbri; M Ronchi; Raffaela Chianese; G Grossi
Lipoperoxide plasma levels in patients with liver cirrhosis.
Hepato-gastroenterology 1997;44(15):784-8.
1997: Giampaolo Bianchi; Elisabetta Bugianesi; M Ronchi; Anna Fabbri; Marco Zoli; Giulio Marchesini
Glutathione kinetics in normal man and in patients with liver cirrhosis.
Journal of hepatology 1997;26(3):606-13.
1997: Andrea Fabbri; Giampaolo Bianchi; Mara Brizi; Marco Zoli; Giulio Marchesini
Uncertainty in liver function assessment on the basis of single-point galactose concentration.
Digestion 1997;58(4):379-83.
1997: Giampaolo Bianchi; M Ronchi; Giulio Marchesini
Effect of lactulose on carbohydrate metabolism and diabetes mellitus.
Scandinavian journal of gastroenterology. Supplement 1997;222():62-4.
1996: Marco Zoli; Carlo Merkel; Donatella Magalotti; Giulio Marchesini; Angelo Gatta; E Pisi
Evaluation of a new endoscopic index to predict first bleeding from the upper gastrointestinal tract in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1996;24(5):1047-52.
1996: Marco Zoli; Donatella Magalotti; G Ghigi; Giulio Marchesini; E Pisi
Transdermal nitroglycerin in cirrhosis. A 24-hour echo-Doppler study of splanchnic hemodynamics.
Journal of hepatology 1996;25(4):498-503.
1996: Carlo Merkel; Giulio Marchesini; A Fabbri; S Bianco; G Bianchi; E Enzo; David Sacerdoti; Marco Zoli; Angelo Gatta
The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death.
Hepatology (Baltimore, Md.) 1996;24(4):820-3.
1996: Marco Zoli; Donatella Magalotti; Giampaolo Bianchi; C Gueli; Giulio Marchesini; E Pisi
Efficacy of a surveillance program for early detection of hepatocellular carcinoma.
Cancer 1996;78(5):977-85.
1996: A Fabbri; Giampaolo Bianchi; E Motta; Mara Brizi; Marco Zoli; Giulio Marchesini
The galactose elimination capacity test: a study of the technique based on the analysis of 868 measurements.
The American journal of gastroenterology 1996;91(5):991-6.
1996: Giulio Marchesini; A Fabbri; Giampaolo Bianchi; Mara Brizi; Marco Zoli
Zinc supplementation and amino acid-nitrogen metabolism in patients with advanced cirrhosis.
Hepatology (Baltimore, Md.) 1996;23(5):1084-92.
1996: A Fabbri; N Magrini; Giampaolo Bianchi; Marco Zoli; Giulio Marchesini
Overview of randomized clinical trials of oral branched-chain amino acid treatment in chronic hepatic encephalopathy.
JPEN. Journal of parenteral and enteral nutrition 1996;20(2):159-64.
1996: Elisabetta Bugianesi; A Tangerman; M Ronchi; Giampaolo Bianchi; Giulio Marchesini
Transamination of methionine after loading in patients with cirrhosis.
Journal of hepatology 1996;24(1):95-100.
1995: Marco Zoli; Donatella Magalotti; M Grimaldi; C Gueli; Giulio Marchesini; E Pisi
Physical examination of the liver: is it still worth it?
The American journal of gastroenterology 1995;90(9):1428-32.
1995: Marco Zoli; Donatella Magalotti; Giampaolo Bianchi; G Ghigi; C Orlandini; M Grimaldi; Giulio Marchesini; E Pisi
Functional hepatic flow and Doppler-assessed total hepatic flow in control subjects and in patients with cirrhosis.
Journal of hepatology 1995;23(2):129-34.
1995: Giampaolo Bianchi; Giulio Marchesini; C Gueli; Marco Zoli
Thyroid involvement in patients with active inflammatory bowel diseases.
The Italian journal of gastroenterology 1995;27(6):291-5.
1995: A Fabbri; Giampaolo Bianchi; Mara Brizi; Elisabetta Bugianesi; Gabriele Grossi; R Flamia; Marco Zoli; Giulio Marchesini
Effects of beta-blockade on hepatic conversion of amino acid nitrogen and on urea synthesis in cirrhosis.
Metabolism: clinical and experimental 1995;44(7):899-905.
1994: A Fabbri; Giulio Marchesini; Giampaolo Bianchi; Elisabetta Bugianesi; Marco Zoli; E Pisi
Kinetics of hepatic amino-nitrogen conversion in ageing man.
Liver 1994;14(6):288-94.
1994: Giulio Marchesini; A Fabbri; Giampaolo Bianchi; E Motta; P Giovanelli; D Urbini; A Lodi
Hepatic conversion of amino-nitrogen to urea in thyroid diseases. II. A study in hyperthyroid patients.
Metabolism: clinical and experimental 1994;43(8):1023-9.
1994: A Fabbri; E Motta; Stefano Ferrari; C Longhi; E Marchi; Gaetano Bacci; E Figus; Giulio Marchesini
High-dose methotrexate treatment and liver function in patients with osteosarcoma.
Journal of internal medicine 1994;236(2):209-14.
1994: Giampaolo Bianchi; Giulio Marchesini; Marco Zoli; Elisabetta Bugianesi; A Fabbri; E Pisi
Prognostic significance of diabetes in patients with cirrhosis.
Hepatology (Baltimore, Md.) 1994;20(1 Pt 1):119-25.
1994: Giampaolo Bianchi; P L Fiorella; Alberto M Bargossi; Gabriele Grossi; Giulio Marchesini
Reduced ubiquinone plasma levels in patients with liver cirrhosis and in chronic alcoholics.
Liver 1994;14(3):138-40.
1994: Giampaolo Bianchi; Maria Stella De Mitri; Elisabetta Bugianesi; R Abbiati; A Fabbri; Giulio Marchesini
Lowering effects of a preparation containing fibres and lactulose on glucose and insulin levels in obesity.
The Italian journal of gastroenterology 1994;26(4):174-8.
1993: Giampaolo Bianchi; Giulio Marchesini; Marco Zoli; M C Falasconi; T Iervese; F Vecchi; Donatella Magalotti; S Ferri
Thyroid involvement in chronic inflammatory rheumatological disorders.
Clinical rheumatology 1993;12(4):479-84.
1993: Giampaolo Bianchi; Giulio Marchesini; Roberto Bolzani; A Fabbri; E Sarti; E Pisi
Model-derived assessment of urea appearance in response to alanine infusion: a quantitative measure of liver function in cirrhosis.
Journal of gastroenterology and hepatology 1993;8(6):550-6.
1993: Giulio Marchesini; A Fabbri; Giampaolo Bianchi; E Motta; Elisabetta Bugianesi; D Urbini; A Pascoli; A Lodi
Hepatic conversion of amino nitrogen to urea nitrogen in hypothyroid patients and upon L-thyroxine therapy.
Metabolism: clinical and experimental 1993;42(10):1263-9.
1993: A Fabbri; Giulio Marchesini; Giampaolo Bianchi; Elisabetta Bugianesi; L Bortoluzzi; Marco Zoli; E Pisi
Unresponsiveness of hepatic nitrogen metabolism to glucagon infusion in patients with cirrhosis: dependence on liver cell failure.
Hepatology (Baltimore, Md.) 1993;18(1):28-35.
1993: Giampaolo Bianchi; Giulio Marchesini; A Fabbri; A Rondelli; Elisabetta Bugianesi; Marco Zoli; E Pisi
Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross-over comparison.
Journal of internal medicine 1993;233(5):385-92.
1993: Giulio Marchesini; A Fabbri; Elisabetta Bugianesi; Giampaolo Bianchi
Glucagon and amino acid disposal in normal man and in patients with cirrhosis.
The Italian journal of gastroenterology 1993;25(2):93-8.
1993: Giampaolo Bianchi; Roberto Bolzani; Giulio Marchesini; E Sarti
Mathematical modelling of amino acid-derived urea synthesis.
The Italian journal of gastroenterology 1993;25(2):87-92.
1993: Marco Zoli; T Iervese; Carlo Merkel; Giampaolo Bianchi; Donatella Magalotti; Giulio Marchesini; Angelo Gatta; E Pisi
Prognostic significance of portal hemodynamics in patients with compensated cirrhosis.
Journal of hepatology 1993;17(1):56-61.
1992: Giampaolo Bianchi; Giulio Marchesini; Marco Zoli; R Abbiati; E Ferrario; A Fabbri; E Pisi
Oral BCAA supplementation in cirrhosis with chronic encephalopathy: effects on prolactin and estradiol levels.
Hepato-gastroenterology 1992;39(5):443-6.
1992: R Lolli; Giulio Marchesini; Giampaolo Bianchi; A Fabbri; Elisabetta Bugianesi; Marco Zoli; E Pisi
Anthropometric assessment of the nutritional status of patients with liver cirrhosis in an Italian population.
The Italian journal of gastroenterology 1992;24(8):429-35.
1992: Giulio Marchesini; G A Checchia; Claudio Stefanelli; Giampaolo Bianchi; A Fabbri; Marco Zoli; C M Caldarera; E Pisi
Polyamine plasma levels and liver regeneration following partial hepatic resection in man.
Journal of hepatology 1992;16(1-2):159-64.
1992: Giulio Marchesini; Elisabetta Bugianesi; Giampaolo Bianchi; A Fabbri; E Marchi; Marco Zoli; E Pisi
Defective methionine metabolism in cirrhosis: relation to severity of liver disease.
Hepatology (Baltimore, Md.) 1992;16(1):149-55.
1991: Marco Zoli; M R Cordiani; Giulio Marchesini; T Iervese; A M Labate; C Bonazzi; Giampaolo Bianchi; E Pisi
Prognostic indicators in compensated cirrhosis.
The American journal of gastroenterology 1991;86(10):1508-13.
1991: Carlo Merkel; Angelo Gatta; Marco Zoli; Massimo Bolognesi; Paolo Angeli; T Iervese; Giulio Marchesini; A Ruol
Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score.
Digestive diseases and sciences 1991;36(9):1197-203.
1991: Giampaolo Bianchi; Marco Zoli; Giulio Marchesini; Umberto Volta; F Vecchi; T Iervese; C Bonazzi; E Pisi
Thyroid gland size and function in patients with cirrhosis of the liver.
Liver 1991;11(2):71-7.
1991: Giampaolo Bianchi; Giulio Marchesini; H Vilstrup; A Fabbri; Maria Stella De Mitri; Marco Zoli; E Pisi
Hepatic amino-nitrogen clearance to urea-nitrogen in control subjects and in patients with cirrhosis: a simplified method.
Hepatology (Baltimore, Md.) 1991;13(3):460-6.
1991: A Fabbri; Giampaolo Bianchi; Marco Zoli; E Marchi; Giulio Marchesini
Effect of physical exercise on one-sample antipyrine clearance.
The Italian journal of gastroenterology 1991;23(2):74-6.
1990: Giulio Marchesini; G Pacini; Giampaolo Bianchi; D Patrono; C Cobelli
Glucose disposal, beta-cell secretion, and hepatic insulin extraction in cirrhosis: a minimal model assessment.
Gastroenterology 1990;99(6):1715-22.
1990: Roberto Bolzani; Giampaolo Bianchi; Giulio Marchesini; E Sarti
Mathematical model to analyse urea synthesis following alanine infusion in control subjects and in patients with liver cirrhosis.
Medical & biological engineering & computing 1990;28(4):325-8.
1990: Giulio Marchesini; Francesco Saverio Dioguardi; Giampaolo Bianchi; Marco Zoli; Giorgio Bellati; Luigi Roffi; D Martines; R Abbiati
Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group.
Journal of hepatology 1990;11(1):92-101.
1990: Giulio Marchesini; A Fabbri; Elisabetta Bugianesi; Giampaolo Bianchi; E Marchi; Marco Zoli; E Pisi
Analysis of the deterioration rates of liver function in cirrhosis, based on galactose elimination capacity.
Liver 1990;10(2):65-71.
1990: Marco Zoli; M R Cordiani; Giulio Marchesini; S Abbati; Giampaolo Bianchi; E Pisi
Ultrasonographic follow-up of liver cirrhosis.
Journal of clinical ultrasound : JCU 1990;18(2):91-6.
1990: Giulio Marchesini; Giampaolo Bianchi; A Fabbri; R Lolli; Elisabetta Bugianesi; Marco Zoli; E Pisi
Synthesis of urea after a protein-rich meal in normal man in relation to ageing.
Age and ageing 1990;19(1):4-10.
1989: Giulio Marchesini; Giampaolo Bianchi
Carbohydrate metabolism in hepatocellular carcinoma: where does the glucose go?
Hepatology (Baltimore, Md.) 1989;10(2):253-5.
1989: Marco Zoli; P Pisi; Giulio Marchesini; Giampaolo Bianchi; G A Turci; E Pisi
A rapid method for the in vivo measurement of liver volume.
Liver 1989;9(3):159-63.
1989: Marco Zoli; T Iervese; S Abbati; Giampaolo Bianchi; Giulio Marchesini; E Pisi
Portal blood velocity and flow in aging man.
Gerontology 1989;35(2-3):61-5.
1988: Giulio Marchesini; V Bua; A Brunori; Giampaolo Bianchi; P Pisi; A Fabbri; Marco Zoli; E Pisi
Galactose elimination capacity and liver volume in aging man.
Hepatology (Baltimore, Md.) 1988;8(5):1079-83.
1988: Giulio Marchesini; G A Checchia; Gabriele Grossi; R Lolli; Giampaolo Bianchi; Marco Zoli; E Pisi
Caffeine intake, fasting plasma caffeine and caffeine clearance in patients with liver diseases.
Liver 1988;8(4):241-6.
1987: Giulio Marchesini; S Cassarani; G A Checchia; Giampaolo Bianchi; V Bua; Marco Zoli; E Pisi
Insulin resistance in aged man: relationship between impaired glucose tolerance and decreased insulin activity on branched-chain amino acids.
Metabolism: clinical and experimental 1987;36(11):1096-100.
1987: Giulio Marchesini; Giampaolo Bianchi; Gabriele Forlani; A G Rusticali; D Patrono; M Capelli; Marco Zoli; P Vannini; E Pisi
Insulin resistance is the main determinant of impaired glucose tolerance in patients with liver cirrhosis.
Digestive diseases and sciences 1987;32(10):1118-24.
1987: Giulio Marchesini; Giampaolo Bianchi; H Vilstrup; G A Checchia; D Patrono; Marco Zoli
Plasma clearances of branched-chain amino acids in control subjects and in patients with cirrhosis.
Journal of hepatology 1987;4(1):108-17.
1986: Marco Zoli; Giulio Marchesini; A Brunori; M R Cordiani; E Pisi
Portal venous flow in response to acute beta-blocker and vasodilatatory treatment in patients with liver cirrhosis.
Hepatology (Baltimore, Md.) 1986;6(6):1248-51.
1986: Marco Zoli; Giulio Marchesini; A Melli; G Viti; A Marra; Domenico Marrano; E Pisi
Evaluation of liver volume and liver function following hepatic resection in man.
Liver 1986;6(5):286-91.
1986: Marco Zoli; A Melli; G Viti; A Marra; Giulio Marchesini
Sonographic evaluation of liver, spleen, and splanchnic vessels following partial liver resection.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 1986;5(10):563-7.
1986: Marco Zoli; Giulio Marchesini; M R Cordiani; P Pisi; A Brunori; A Trono; E Pisi
Echo-Doppler measurement of splanchnic blood flow in control and cirrhotic subjects.
Journal of clinical ultrasound : JCU 1986;14(6):429-35.
1985: Marco Zoli; C Dondi; Giulio Marchesini; M R Cordiani; A Melli; E Pisi
Splanchnic vein measurements in patients with liver cirrhosis: a case-control study.
Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine 1985;4(12):641-6.
1985: Giulio Marchesini; A Melli; G A Checchia; L Mattioli; M Capelli; S Cassarani; Marco Zoli; E Pisi
Pancreatic beta-cell function in cirrhotic patients with and without overt diabetes. C-peptide response to glucagon and to meal.
Metabolism: clinical and experimental 1985;34(8):695-701.
1985: Marco Zoli; Giulio Marchesini; Antonio Marzocchi; Cinzia Marrozzini; C Dondi; E Pisi
Portal pressure changes induced by medical treatment: US detection.
Radiology 1985;155(3):763-6.
1984: P Vannini; Gabriele Forlani; Giulio Marchesini; A Ciavarella; Marco Zoli; E Pisi
The euglycemic clamp technique in patients with liver cirrhosis.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 1984;16(7):341-3.
1984: Gabriele Forlani; P Vannini; Giulio Marchesini; Marco Zoli; A Ciavarella; E Pisi
Insulin-dependent metabolism of branched-chain amino acids in obesity.
Metabolism: clinical and experimental 1984;33(2):147-50.
1983: L Liguori; Orazio Campione; Giulio Marchesini; C A Roversi; S Vatrella; A Melli; Vincenzo Maria Greco; Domenico Marrano
[Acute experimental hepatic insufficiency in pigs. Validity of a model with biohumoral and electroencephalographic monitoring].
Archivio per le scienze mediche 1983;140(4):405-11.
1983: Giulio Marchesini; Giampaolo Bianchi; Marco Zoli; C Dondi; Gabriele Forlani; A Melli; V Bua; P Vannini; E Pisi
Plasma amino acid response to protein ingestion in patients with liver cirrhosis.
Gastroenterology 1983;85(2):283-90.
1983: Giulio Marchesini; Gabriele Forlani; Marco Zoli; C Dondi; Giampaolo Bianchi; V Bua; P Vannini; E Pisi
Effect of euglycemic insulin infusion on plasma levels of branched-chain amino acids in cirrhosis.
Hepatology (Baltimore, Md.) 1983;3(2):184-7.
1983: Domenico Marrano; G Plicchi; L Liguori; Giulio Marchesini; Orazio Campione; M Spighi; C A Roversi; V Betti; S Vatrella; A Melli
A combined charcoal-resin hemoperfusion system in acute experimental hepatic failure in pigs. Depurative activity on plasma amino acids.
Life support systems : the journal of the European Society for Artificial Organs 1983;1 Suppl 1():74-7.
1982: Giulio Marchesini; Gabriele Forlani; Marco Zoli; P Vannini; E Pisi
Muscle protein breakdown in uncontrolled diabetes as assessed by urinary 3-methylhistidine excretion.
Diabetologia 1982;23(5):456-8.
1982: Giulio Marchesini; Marco Zoli; C Dondi; Giampaolo Bianchi; M Cirulli; E Pisi
Anticatabolic effect of branched-chain amino acid-enriched solutions in patients with liver cirrhosis.
Hepatology (Baltimore, Md.) 1982;2(4):420-5.
1982: Marco Zoli; Giulio Marchesini; C Dondi; Giampaolo Bianchi; E Pisi
Myofibrillar protein catabolic rates in cirrhotic patients with and without muscle wasting.
Clinical science (London, England : 1979) 1982;62(6):683-6.
1982: Giulio Marchesini; Marco Zoli; C Dondi; A Angiolini; A Melli; E Pisi
Ammonia-induced changes in pancreatic hormones and plasma amino acids in patients with liver cirrhosis.
Digestive diseases and sciences 1982;27(5):406-12.
1982: P Vannini; Giulio Marchesini; Gabriele Forlani; A Angiolini; A Ciavarella; Marco Zoli; E Pisi
Branched-chain amino acids and alanine as indices of the metabolic control in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients.
Diabetologia 1982;22(3):217-9.
1981: Giulio Marchesini; Marco Zoli; A Angiolini; C Dondi; F B Bianchi; E Pisi
Muscle protein breakdown in liver cirrhosis and the role of altered carbohydrate metabolism.
Hepatology (Baltimore, Md.) 1981;1(4):294-9.
1981: Marco Zoli; Giulio Marchesini; L Cecchini; C Dondi; F B Bianchi; E Pisi
Binding of tryptophan to albumin in liver cirrhosis: a reappraisal of the problem.
Hepato-gastroenterology 1981;28(2):87-9.
1981: Marco Zoli; Giulio Marchesini; A Angiolini; C Dondi; F B Bianchi; E Pisi
Plasma amino acids as markers of liver dysfunction in cirrhotics.
Scandinavian journal of gastroenterology 1981;16(5):689-92.
1980: Giulio Marchesini; Marco Zoli; C Dondi; L Cecchini; A Angiolini; F B Bianchi; E Pisi
Prevalence of subclinical hepatic encephalopathy in cirrhotics and relationship to plasma amino acid imbalance.
Digestive diseases and sciences 1980;25(10):763-8.